The online Professional Certificate of Medical Business Management course equips medical practitioners, partners, and practice managers with the practical know-how to operate a successful practice amid a challenging primary care landscape.

Delivered by experienced industry experts, the certificate course teaches fundamental knowledge in medical practice ownership, including various business structures, accounting and taxation requirements, marketing strategies, staff recruitment techniques, operational procedures for running a successful medical clinic, IT considerations, and more.

This course is the first stage of the three-part Professional Diploma of Medical Business Management. The education pathway is Professional Certificate of Medical Business Management, Advanced Certificate of Medical Business Management and Professional Diploma of Medical Business Management

Professional Certificate of  Medical Business Management       YOU ARE HERE Advanced Certificate of   Medical Business Management      LEARN MORE Professional Diploma of   Medical Business Management      LEARN MORE



This Professional Certificate of Medical Business Management course is for medical professionals, partners and practice managers. This qualification is the first stage of the three-part Professional Diploma of Medical Business Management program. There are no prerequisites. Participants do not have to pass an IELTS test but, as the courses are delivered in English, proficiency in listening, reading and writing English is assumed.

Participants will require access to a computer/laptop, an internet connection and a basic level of technology proficiency to access and navigate the online learning portal.

Professionally recognised qualifications and prior studies may be recognised for entry into this course if the learning outcomes match exactly. Please ask a HealthCert Education Advisor for an individual assessment of your prior qualifications and experience.


  • Understanding your goals in business ownership
  • Business structure & strategy: Fundamentals & managing partnerships
  • Finance fundamentals: Understanding financial statements, budgeting & reporting
  • Marketing fundamentals: Ideal patients, marketing channels & positioning your practice in the market
  • Human resources: Staff
  • Operations management: Key people, SOPs, rostering, health & safety
  • Patients: Expectations, services, satisfaction, safety & engagement
  • IT & cybersecurity

Course participants will:

  • Participate in online interactive tutorials with experts and professional colleagues.
  • Develop policies, procedures and forms for your own clinics based on templates provided.
  • Gain access to all course materials online 24 hours a day, 7 days a week - including video lectures, presentation slides and additional resources (such as templates, checklists, and supporting activities) to help you implement your learning.
  • Receive ongoing support post-course through webinars and case review.
  • Receive unlimited and ongoing access to free alumni learning resources, video lectures, and discussion forums, as well as invite-only events and special offers after completion of the course.


Module 1: Introduction to the endocannabinoid system

Module 2: Exploring THC and CBD

Module 3: Routes of administration, side effects and contraindications

Module 4: Patient cases and basic ailments

Module 5: History of cannabis and medical acceptance

Module 6: Chronic pain and medical cannabis

Module 7: Anxiety, insomnia and depression

Module 8: Cancer symptomatic treatment


Module One: History of Cannabis and Medical Acceptance

This module considers the cannabis plant and its rich and colourful history as a psychotropic agent, a commodity, a sacred entity, and a medicine to treat a raft of disorders. Maligned and criminalised in the second half of the 20th century, cannabis is now in a new cycle with a burgeoning and sustained scientific interest in its potential medical uses. The module also outlines the history behind the discovery of different cannabis strains, specific phytocannabinoids (e.g., THC), endocannabinoids (e.g., AEA) and the body’s innate endocannabinoid system, and the myriad of biological processes to which it is linked. Finally, the module looks at the discovery of terpenes, and with it, the so-called entourage effect or the synergism between the multitude of compounds within the whole plant.

Module Five: Patient Cases and Basic Ailments

This module identifies a number of basic ailments that may be successfully treated with medical cannabis in General Practice. For example, the adverse effects of cancer treatment, the symptoms of chronic pain, anxiety, depression, and insomnia could be alleviated by medicinal cannabis with mild side effects and minimal risk of toxicity or addiction. Providing that conventional treatments have failed or caused unacceptable side effects, a growing number of conditions lend themselves to treatment with cannabis. Given the complex chemical profile, there is a single medication potential to assist with multiple symptoms, thereby reducing polypharmacy. The module applies an individualised management plan to three comprehensive case studies for patients with chronic pain, osteoarthritis, and anxiety and depression. Considerations ranging from the cost to the patient to the appropriate THC to CBD ratio are addressed. Finally, the module guides the practitioner in navigating an application for a TGA Special Access Scheme/SAS B.

Module Two: Introduction to the Endocannabinoid System
This module analyses the homeostatic endocannabinoid system and its broad scope of influence in both health and disease. The endocannabinoid system’s three central instruments are established, the endocannabinoids, receptors, and enzymes, followed by an analysis of the system’s homeostatic functions, including analgesia, mood, energy balance, and stress coping. Evidence for the relationship between insufficiency or dysregulation of the endocannabinoid system and particular disorders is also discussed. Finally, the module provides an overview of our current understanding of cannabinoids, such as THC and CBD, and how ongoing research into targeted manipulation of the endocannabinoid system with active cannabinergic compounds may prove therapeutic in numerous pathological conditions.

Module Six: Chronic Pain and Medicinal Cannabis
This module discusses the use of medicinal cannabis as an emerging option for clinicians to reduce and alleviate difficult-to-treat, chronic, neuropathic pain. The module analyses the endocannabinoid system and the diverse, multimodal mechanisms of cannabinoid-induced analgesia. THC and CBD are an excellent additive treatment to concurrent conventional pain management for many chronic pain types associated with a range of diseases such as fibromyalgia, traumatic injury, and multiple sclerosis. For patients suffering from neuropathic pain, cannabinoids may be used successfully as an adjunctive, opioid-sparing, or ultimately a replacement therapy for managing their pain. The module also discusses a management plan’s necessary considerations (such as determining dosages and accounting for safety considerations) and applies these protocols to a chronic pain case study.

Module Three: Exploring THC and CBD
This module provides a comprehensive examination of the two main cannabinoids, tetrahydrocannabinol (THC) and cannabidiol (CBD); it distinguishes between their main actions and analyses their synergistic relationship. Given that THC and CBD interact differently within the endocannabinoid system and with other neurotransmitters, the module considers their different therapeutic potential, bioavailability, metabolism, toxicology, and dosing. The module also describes the most up-to-date method of cannabis classification, or chemovars, a method based on chemical composition in order to match a specific profile to a particular treatment. For example, chemovars establish the CBD to THC ratio in a given ‘species’ as well as other cannabinoids involved in whole plant medicine, such as CBG, CBN, and CBC. They also determine the presence of other important constituents, such as a wide variety of terpenes.

Module Seven: Anxiety, Insomnia and Depression
This module examines the homeostatic functions of the endocannabinoid system in relation to mood, stress response, and sleep. It also evaluates the therapeutic capacity of the major cannabinoids (THC and CBD), in isolation and in synergy, in relation to anxiety, depression, and insomnia. In developing a treatment plan, essential factors such as the interplay between depression, anxiety, pain, and insomnia are considered, as well as protocols for THC to CBD ratios in basic dosing, and the route and timing of administration with reference to each condition. With regard to treating insomnia particularly, the module addresses the role of other lesser-known cannabinoids, such as CBN, and terpenes. Pertinent considerations such as the dampening effect of CBD upon the undesirable effects of THC such as intoxication, tachycardia and psycho-activity (of particular importance when treating anxiety) are also discussed.

Module Four: Routes of Administration, Side Effects and Contra Indications
This module discusses the safe use of medicinal cannabis, outlining the routes of administration, side effects, and contraindications. Cannabinoid pharmacokinetics are also examined, including its absorption following diverse administration routes, metabolism by different tissues and organs, bioavailability and elimination from the body. Despite its extreme safety as a medication generally and particularly relative to opioids, potential adverse effects and contrindicaitons of cannabis are outlined. The module also analyses the potential for drug-to-drug interaction given CBD and THC’s effects on common biological pathways implicated in drug metabolism via their interactions with cytochrome P450 enzymes specifically.

Module Eight: Cancer: Symptomatic Treatment
This module reviews the myriad of functions of cannabinoids and the endocannabinoid system and considers the supportive role they may have to play in cancer therapy. Although research continues into the anti-tumour properties of cannabinoids, there is currently no evidence that medical cannabis can cure or even treat cancer. Nonetheless, it can be a successful additional therapy used in the management of cancer symptoms and the iatrogenic effects of treatment. The judicious use of medicinal cannabis can significantly improve cancer sufferers’ quality of life by managing persistent symptoms and side effects such as, cancer pain, nausea, vomiting, and chemotherapy-induced nausea and vomiting. The module also considers the case studies of three different cancer patients and, for each, examines issues for the clinician related to assessment, dosing recommendations, formulation, methods of administration, and side effects.




From $1,495




Save up to $300

For doctors in training who are on a pathway to General Practice Registration through a recognised training provider.


Save up to $568

Enrol in two or three courses within the same education pathway to optimise your savings.


Monthly from $395

Enrol in one, two or three courses within a pathway now and pay later in small monthly instalments.

*The individual offers and special rates cannot be used in conjunction with any other specials. 


Meet your instructors

HealthCert has a high-quality team of industry professionals to deliver this course. The Course Development Committee are medical business professionals led by the founder and CEO of HealthCert, Paul Elmslie. Paul also leads a group of medical centres throughout Australia with hundreds of General Practitioners.
Paul Elmslie-1

Paul Elmslie

Founder & CEO, HealthCert & National Skin Cancer Centres 

Paul Elmslie has over 20 years' work experience with a focus on skin cancer. An early pioneer in the development of skin cancer clinics, Paul operates Australia's leading network of dedicated skin cancer facilities and continues to lead the industry through HealthCert Education, the world's first integrated university-assured education provider for medical professionals. Paul has authored books and speaks at conferences all over the world. He has completed business programs with Harvard, MIT and London School of Business, and holds an MBA.

Matt Woollard__1

Matt Woollard

Chief Operations Officer, National Skin Cancer Centres

Born and educated in Adelaide, a true entrepreneur, Matt Woollard has run various businesses in the areas of advertising, entertainment and retail. 

Matt began his career in skin cancer in 2000 as the second employee of Skin Alert. He worked alongside Paul Elmslie to grow the company to 14 skin cancer clinics throughout Australia in seven years. 

Matt has worked as a consultant in education with companies like HealthCert, Notre Dame Australia, University of Melbourne, The University of Queensland, Zimmer, NSW Health and the RACGP. 

Matt is now the Chief Operations Officer of National Skin Cancer Centres (NSCC). Established in 2016, NSCC builds and operates skin cancer clinics across Australia, starting out with just one centre and now expanding to eight, with another 22 scheduled to join the group. 

Matt’s area of expertise in the industry is operations, based on a very strong understanding of skin cancer medicine including all aspects of Medicare in primary care.

Adam Kostanski

Medical Director, OzDoc

Alan Miltz__1

Alan Miltz

Founder, Cash Flow Story

Paul Gwilym

FinTech Consulting Ventures


The Professional Certificate of Medical Business Management is fully delivered online. Participants can enjoy the flexibility to study at their own pace, in their own time, within their home or office, and on their favourite mobile device. The modules are set up in such a way that participants are not required to be online at specific times but can view and replay the video lectures at their convenience.

There are eight units in a HealthCert Professional Certificate program. Course learning materials will be available for a minimum of 15 weeks. There will be pre-reading activities, online materials, interactive online tutorials, individual tasks to complete and two online examinations.

The course includes: 

  • Online interactive tutorials with experts and professional colleagues.
  • All presentation slides available for download.
  • Access to additional learning resources, reference materials and video lectures.
  • Templates, checklists, and supporting activities to help you implement your learning.


In order to meet the requirements of professional and academic learning, the course assessment includes a professional planning requirement and two online examinations.

Professional planning requirement

  • Provide an explanation of how you intend to use the learning from this course in your professional work.  

Online examinations

  • 88 knowledge questions based on a scenario of a medical practitioner undertaking special interest training. Questions relate to facts, information and theory requiring judgements and decisions.
    • Example: The medical clinic manager believes that… Is he/she correct? Yes/No.
  • 88 authentic scenario-based questions based on management at a medical clinic. Questions based on application and cases requiring judgements and decisions.
    • Example: A medical clinic manager has this problem… what should he/she do? Multiple Choice.

The knowledge-based examination is worth 50% and the application-based examination is worth 50%. The overall pass mark is 80%. It is therefore not possible to pass this course on knowledge alone; knowledge must be successfully applied to patient cases in order to pass the course.

HealthCert recommends completion of the assessment at your convenience within three months of the completion of the course (or enrolling in the online course).


50 Hours CPD logo

This certificate course meets the minimum 50 hours CPD annual requirement across all three mandatory CPD activity types.


PCMBM certificate imageUpon successful completion, course participants will receive a Professional Certificate of Medical Business Management.

This Professional Certificate:

  • Provides CPD hours: Royal Australian College of General Practitioners (RACGP).
  • Provides CPD hours: Australian Council of Rural and Remote Medicine (ACRRM).
  • Is recognised by Royal New Zealand College of General Practitioners (RNZCGP).
  • Is recognised by the Hong Kong College of Family Physicians (HKCFP). Points are calculated differently.
  • Compulsifies peer review and audit.


This online three-part program consists of the Professional Certificate, Advanced Certificate, and Professional Diploma of Medical Cannabis.


Certified clinical attachments pathway

Course graduates may continue their professional development by completing a clinical attachment, which are available on request. These will be on a 1:1 basis providing the opportunity to observe clinical nutrition consultation, planning and decision-making and ask questions of the expert. Clinical attachments are available in Australia.


Postgraduate pathway for Medical Cannabis

A postgraduate pathway is currently being identified. Please check with HealthCert Education Advisors for an update.